Our Services
Medical Information
Helpful Resources
Published on: 5/6/2026
CJC-1295 raises growth hormone and IGF-1 levels, which can trigger sodium retention, capillary leak, and hormonal shifts. This often leads to swelling (edema) in the ankles, feet, hands, or face—particularly at higher doses or in people with underlying health conditions. Several factors influence how and when swelling occurs, so review the full analysis below.
Medically approved next steps—including dose adjustments, dietary and lifestyle changes, over-the-counter supports, and guidance on when to seek further testing—are outlined below.
Because swelling can stem from many causes beyond peptide use (kidney, heart, thyroid, or circulatory issues), it's smart to rule out other contributors quickly. Take a free, instant, online symptom check to clarify what's driving your swelling and confidently plan your next steps.
Reviewed for medical accuracy: 07/10/2026
CJC-1295 is a popular synthetic peptide often used to boost growth hormone (GH) levels. While many users report benefits like improved muscle tone, better sleep and faster recovery, one potential side effect is water retention. In this article, we'll explore what water retention is, why CJC-1295 can cause swelling, how to recognize it and what medically approved next steps you can take.
Water retention, also known as edema, occurs when excess fluid builds up in your body's tissues. Common signs include:
Edema can range from mild and temporary to more severe, requiring medical attention.
CJC-1295 stimulates the release of growth hormone and subsequently increases Insulin-Like Growth Factor-1 (IGF-1). Both GH and IGF-1 have fluid-retaining effects:
Increased Sodium Retention
Capillary Permeability Changes
Hormonal Shifts
While anyone using CJC-1295 might experience some fluid shifts, certain factors increase the risk:
Keep an eye on your body for these common indicators:
If you notice these signs, it's time to take action.
Most mild cases of edema can be managed at home. However, contact your healthcare provider or seek immediate care if you experience:
If you're uncertain about the severity of your symptoms, you can start by taking a free AI-powered symptom assessment to receive personalized insights about your condition and help determine if you need immediate medical attention.
To rule out other causes and check severity, a physician may recommend:
CJC-1295 can offer real improvements in body composition, recovery and vitality. Yet, like any hormone-modulating therapy, it carries potential side effects, with water retention being one of the most common. By:
you can maximize benefits while minimizing discomfort.
Water retention from CJC-1295 is usually manageable without alarm. Honest tracking and simple lifestyle shifts often bring relief. However, never ignore signs that could point to a more serious issue.
If you're concerned about your symptoms or are experiencing anything that feels alarming, please speak to a doctor promptly. Your health and safety come first. For a quick evaluation of whether your symptoms require urgent attention, consider using a free AI symptom checker and always follow up with a qualified healthcare professional.
(References)
* van der Lely, A. J., et al. (2006). Safety, tolerability, and pharmacokinetics of CJC-1295, a long-acting growth hormone-releasing hormone analogue, in healthy adults. *The Journal of Clinical Endocrinology & Metabolism*, *91*(1), 164-169. PMID: 16867972.
* Jørgensen, J. O., et al. (2000). Growth hormone and fluid retention. *Progress in Brain Research*, *128*, 297-307. PMID: 10850020.
* Grinspoon, S., et al. (2010). Tesamorelin, a growth hormone-releasing factor analog, in HIV-infected patients with abdominal fat accumulation: a randomized controlled trial. *The New England Journal of Medicine, 362*(1), 31-42. PMID: 20040625.
* Johannsson, G., et al. (1994). Fluid retention in patients with growth hormone deficiency treated with recombinant human growth hormone. *Metabolism, 43*(8), 1026-1030. PMID: 8092716.
* Popovic, V., et al. (2011). Growth hormone-releasing hormone (GHRH) and its analogs: potential therapeutic applications. *The Journal of Clinical Endocrinology & Metabolism, 96*(3), 616-625. PMID: 21193540.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.